OncoRNA

Location

charleroi

Region

wallonia

Founded

2023

Status

active

Website

oncorna.eu

Sector

biotech, medtech, deeptech

TLDR

OncoRNA develops personalized mRNA-based cancer immunotherapy vaccines that direct patients' immune systems against their tumors.

Overview

OncoRNA is developing next-generation personalized cancer immunotherapy using mRNA vaccine technology. The company was selected by the European Commission for the IPCEI Med4Cure project and aims to deliver personalized cancer immunotherapy batches within 3 weeks using synthetic DNA production methods.